In-Jae Oh

About In-Jae Oh

In-Jae Oh, With an exceptional h-index of 34 and a recent h-index of 24 (since 2020), a distinguished researcher at Chonnam National University, specializes in the field of Lung cancer, Pulmonary research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Early Diagnosis of Lung Cancer by Detecting Tumor Originated Deoxyribo Nucleic Acid (DNA) Fragments Using Plasma Cell-free DNA Methylome and Fragmentome Profiles

Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial

Abstract CT252: Nicotinamide in combination with EGFR-TKIs for the treatment of stage IV lung adenocarcinoma with EGFR mutations: A randomized double-blind (Phase IIb) trial

Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8+ T cells in murine models of inflammation

Exploring the therapeutic potential of EGFR retreatment: A comprehensive analysis of T790m (+) conversion and prognosis in lung cancer patients

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Blood lymphocytes as a prognostic factor for stage III non-small cell lung cancer with concurrent chemoradiation

A Phase 2, Multicenter, Single Arm Study to Evaluate the Efficacy of Lazertinib in Patients with NSCLC Who Harboring EGFR T790M Mutation Detected by BALF Liquid Biopsy: Interim …

In-Jae Oh Information

University

Position

Department of Internal Medicine Medical School

Citations(all)

4390

Citations(since 2020)

2420

Cited By

2875

hIndex(all)

34

hIndex(since 2020)

24

i10Index(all)

96

i10Index(since 2020)

66

Email

University Profile Page

Google Scholar

In-Jae Oh Skills & Research Interests

Lung cancer

Pulmonary research

Top articles of In-Jae Oh

Early Diagnosis of Lung Cancer by Detecting Tumor Originated Deoxyribo Nucleic Acid (DNA) Fragments Using Plasma Cell-free DNA Methylome and Fragmentome Profiles

2024/5

Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial

Clinical Cancer Research

2024/4/15

In-Jae Oh
In-Jae Oh

H-Index: 24

Young-Chul Kim
Young-Chul Kim

H-Index: 60

Abstract CT252: Nicotinamide in combination with EGFR-TKIs for the treatment of stage IV lung adenocarcinoma with EGFR mutations: A randomized double-blind (Phase IIb) trial

Cancer Research

2024/4/5

In-Jae Oh
In-Jae Oh

H-Index: 24

Young-Chul Kim
Young-Chul Kim

H-Index: 60

Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8+ T cells in murine models of inflammation

Nature Communications

2024/4/4

Exploring the therapeutic potential of EGFR retreatment: A comprehensive analysis of T790m (+) conversion and prognosis in lung cancer patients

Cancer Research

2024/3/22

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Cancers

2024/1/26

In-Jae Oh
In-Jae Oh

H-Index: 24

Eun Young Kim
Eun Young Kim

H-Index: 19

Blood lymphocytes as a prognostic factor for stage III non-small cell lung cancer with concurrent chemoradiation

Chonnam Medical Journal

2024/1

Young-Chul Kim
Young-Chul Kim

H-Index: 60

In-Jae Oh
In-Jae Oh

H-Index: 24

A Phase 2, Multicenter, Single Arm Study to Evaluate the Efficacy of Lazertinib in Patients with NSCLC Who Harboring EGFR T790M Mutation Detected by BALF Liquid Biopsy: Interim …

대한결핵및호흡기학회 추계학술발표초록집

2023

In-Jae Oh
In-Jae Oh

H-Index: 24

Homeostatic Dysregulation of Systemic CD8+ T Cell Compartment in Lung Cancer Patients

bioRxiv

2023

In-Jae Oh
In-Jae Oh

H-Index: 24

Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression

2023/5/1

Clinical Usefulness of Serum KL-6 Test for Predicting Occurrence and Assessing Severity of Treatment-related ILD

2023/5

Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial

Cells

2023/4/25

Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection

Cancers

2023/11/30

Young-Chul Kim
Young-Chul Kim

H-Index: 60

In-Jae Oh
In-Jae Oh

H-Index: 24

Case Report: A case of ultra-late recurrence of KIF13A-RET fusion non-small cell lung cancer response to selpercatinib

Frontiers in Oncology

2023/4/25

Young-Chul Kim
Young-Chul Kim

H-Index: 60

In-Jae Oh
In-Jae Oh

H-Index: 24

Exosome Precipitation by Ionic Strength Modulation: ExoPRISM

ACS Applied Materials & Interfaces

2023/11/28

In-Jae Oh
In-Jae Oh

H-Index: 24

Yoon-Kyoung Cho
Yoon-Kyoung Cho

H-Index: 32

Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Durvalumab after Chemoradiotherapy: PACIFIC-KR.

Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer

2023/4/19

Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)

Cancers

2023/11/24

In-Jae Oh
In-Jae Oh

H-Index: 24

Jiwon Kim
Jiwon Kim

H-Index: 6

Assessment of tumor mutation burden (TMB) based on whole exome sequencing using extracellular vesicles-derived DNA obtained from bronchoalveolar lavage fluid (BALF) in advanced …

Cancer Research

2023/4/4

In-Jae Oh
In-Jae Oh

H-Index: 24

Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data

Translational Lung Cancer Research

2023/11/11

See List of Professors in In-Jae Oh University(Chonnam National University)